Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813280 · ClinicalTrials.gov registry record
Barriers to the Implementation of Complete Insulin Order Sets
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT00813280 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 200 participants.
The verdict
NCT00813280 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG \>300 mg/dl).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813280
The ClinicalTrials.gov registry entry for NCT00813280 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00813280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813280 about?
NCT00813280 is a clinical study titled "Barriers to the Implementation of Complete Insulin Order Sets". The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before an...
What is the current status of trial NCT00813280?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-06. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00813280?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.